Orphan Drugs: Hope Where There Is Little or No Hope

NEW YORK, N.Y., February 18, 2004 ? On a visit to his doctor, Gary Jacob received distressing news ? not about himself, but a friend of the doctor's.

While playing with one of his children, the doctor's friend fell and broke a rib. That was bad enough, but during the examination at the hospital, the father was hit with a startling and totally unexpected diagnosis ? he had a disease known as multiple myeloma, a bone marrow blood cancer.

The diagnosis was nothing less than a death sentence.

Jacob knew of the anguish of multiple myeloma patients. The disease is incurable and nearly always fatal, one of the rare diseases that have few, if any, available treatments. They are known as "orphan" diseases, shunned by most drug-makers because the patient populations are small and commercial development of a drug is seen as economically unattractive.

Mr. Jacob was aware because, as Chief Executive Officer of Callisto Pharmaceuticals, Inc., a small Manhattan-based biopharmaceutical company, he is leading a scientific effort to develop a new orphan drug called "Atiprimod" for multiple myeloma patients.

"The father's disease brought home to me that what we are doing is really important," says Mr. Jacob. "Everyone agrees we need more drugs to treat multiple myeloma. There are people out there dying without real hope because of a lack of effective treatment for all patients."

In steadily increasing numbers, orphan drugs are providing new doses of hope where little or none at all existed. In the decade before the inception of the federal Food and Drug Administration's orphan drug program, 10 drugs were developed by pharmaceutical companies for orphan diseases. In the decades since, the FDA says nearly 250 new drugs were developed and approved, and hundreds more are in the pipeline.

Atiprimod is one of those wending its way toward the marketplace. Callisto recently obtained orphan drug designation from the FDA, providing the company with financial incentives to continue the costly development process.

The program covers drugs for orphan diseases with patient populations under 200,000.

The National Organization for Rare Disorders reports about 25 million people in the United States suffer from an estimated 6,000 orphan diseases.

Diseases such as cystic fibrosis, complications affecting HIV-infected people, Gaucher's disease, hemophilia and rare forms of cancer were among the orphans without effective medicines until the FDA program went into effect in 1983 and paved the way for new drugs for patients with these diseases.

Large drug-makers have been largely missing from the efforts.

According to the orphan drug program's deputy director, Dr. John McCormick, only 15% of applications for orphan drug designation have come from the larger pharmaceutical companies.

The reason: expectations of unfavorable investment returns.

The FDA orphan drug incentives ? grants, seven years of marketing exclusivity and tax breaks ? have drawn small pharmaceutical companies with promising drug candidates into the breach.

While the future is brighter, the task is still daunting to develop drugs for orphan diseases.

Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, affects 30,000 Americans with 8,000 new cases diagnosed annually; Huntington's disease also affects about 30,000 patients.

Some diseases affect fewer than 100 patients, according to the National Institutes of Health.

An estimated 50,000 patients have multiple myeloma with 15,000 new patients diagnosed each year. Last year, the FDA approved a new drug Velcade for patients with the disease. However, there are still a number of multiple myeloma patients with no treatment available.

Dr. Kenneth C. Anderson, who played a major role in the preclinical development and clinical trials of Velcade and is now a member of Callisto's Medical Advisory Board, is among the experts who see a need for more drugs to treat multiple myeloma.

"He is excited to see Atiprimod enter clinical trials for evaluation in multiple myeloma patients," Jacob said of Anderson. "He believes it has an opportunity to help patients who have not responded to other drugs. "

Dr. Anderson is director of the Jerome Lipper Multiple Myeloma Center of the Dana-Farber Cancer Institute in Boston, MA, and Professor of Medicine at Harvard Medical School.

The Phase I/IIa trials for Atiprimod are slated to begin later this month.

Dr. Donald Picker, Callisto's Senior Vice President of Drug Development, said studies of Atiprimod in collaboration with scientists at the National Cancer Institute have been very promising.

"In essence, we've shown in these early studies that Atiprimod has the potential to intervene with cancer cells and tumors in three ways ? by inhibiting their formation, by programming their death and by limiting their ability to grow blood vessels necessary for their survival. Taken together, these findings suggest that Atiprimod could potentially represent a novel class of compounds for development for therapeutic intervention in human cancers," said Dr. Picker.

About The Author

Alex Michelini is a former award-winning reporter/editor at the New York Daily News. His credits include nomination for a Pulitzer Prize for a series on medical costs. Among his honors, Mr. Michelini received the Deadline Club Award, the Page One Award, the Associated Press Award and the New York Press Club Award (twice). He is the founder of Alex Michelini Public Relations, and has developed and collaborated on articles appearing in the New York Times, the Wall Street Journal, the London Times, the New York Post, the New York Daily News, Bloomberg Radio & TV, CNNfn, WCBS Radio & TV. WINS radio, the Christian Science Monitor, Fox TV, Reuters, Newsday and other media outlets.

michelinialex@aol.com

---

Advanced Surface Ablation

In patients with corneal thickness below a certain minimum, performing... Read More

How Is Mold Like AIDS?

Don't laugh. Both get a lot of coverage in the... Read More

Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers

Pharmaceutical giant Bristol Myers Squibb has announced that they will... Read More

Irritable Bowel Syndrome - Cybill Shepherd Reveals All

Cybill Shepherd has revealed that she suffers from irritable bowel... Read More

Phentermine Price Watch: Comparison Shop To Buy Phentermine At The Best Values Online

When compared with the other prescription diet pills, Phentermine is... Read More

Ambien Sleep Medication And Insomnia: What Is Insomnia And How Can Ambien Help?

What's Insomnia?Identifying insomnia is a little like the old joke... Read More

Lunesta Revealed: 7 Things You Must Know Before You Buy Lunesta Prescriptions

Lunesta is a newly released sleeping pill. Marketed as a... Read More

Family Notification in Seven Quick and Easy Steps

The Seven Steps to Successful Notification is an easy-to-use system... Read More

?Get Rid of Tendonitis ? Now!? Advice From An Expert?

Tendons are ropes of fibrous tissue that connect muscles to... Read More

Over The Counter Drugs: How To Safely Choose The Right Medication

What Medication Can Cure Me?1. Am I expecting a cure?... Read More

A Look At Acid Reflux Treatment

Heartburn is a by-product of digestion, specifically affecting the esophagus... Read More

Prescription Drug Side Effects: Treating From The Outside Or The Inside?

Throughout time there have always been two opposing points of... Read More

Cholesterol Treatments Options: Statins

Satins are pharmacuetical drugs that work by restricting the enzyme... Read More

Zoloft Side Effects: Akathisia and Violent Behavior

Zoloft is an SSRI (selective serotonin reuptake inhibitor); a prescription... Read More

Bulk Forming Drugstore Laxatives

There are five basic types of drugstore laxatives you should... Read More

A Fresh Start Plan for People With Neck Pain!

"If you have to deal with chronic neck pain, it... Read More

Where to Find Maryland Drug Rehab Centers?

Everything can be found on the Internet. At various sites... Read More

Buy with confidence at Online Mexican Pharmacy

The foremost benefit of buying prescription medicines and other medical... Read More

Technology Over Drugs for Stress Related Tension Disorders

As much as 95% of the population suffers from some... Read More

A Very Medical Miracle

Madeline Mann once weighed less can a can of soda... Read More

How to Find a Drug Rehab in Florida?

When you're in need, the quickest way is the best:... Read More

Whats a Good Arthritis Medicine for Me, Doctor?

Pain is the body's warning signal that something is wrong.... Read More

Thalidomide

Thalidomide is responsible for causing more than 10,000 children to... Read More

Mexico: Drugs Galore!

You are going to find this incredible and I assure... Read More

10 Steps To Detoxification

Technology. We live in a grand time of technological development.... Read More

The Ease of Using a Motorized Wheelchair to Improve Mobility

No person likes to feel housebound and dependent on others.... Read More

Increase Your Risk of Heart Disease With Lipitor and Pravachol

Results of a new study comparing the effectiveness of Pfizer... Read More

Heel Pain - Ten Tips for Treatment

The most common cause of heel pain is plantar fasciitis... Read More

Health Information: Coping With Stomach Ulcers

Do you suffer from ulcers?If yes, what kind is it... Read More

Bextra and Vioxx -- Alternative Medications Have Warnings, Too

At the urging of the Food and Drug Administration, the... Read More

Rezulin Liver Failure Causes FDA to Recall Drug

Rezulin, a prescription type 2 diabetes drug has been withdrawn... Read More

Amazing Shoulder Pain Reversing Secrets!

Whether you're a weekend athlete, or a gardener that overdid... Read More

Benefits of a Virtual Top Doctor Consultant

Looking for the best doctor to suite your medical needs... Read More